marketing@welldoc.com
443-692-3107
PR & Communications
Media Contact
Welldoc® is a leading digital health company revolutionizing chronic disease management to help transform lives. BlueStar helps guide individuals through the complicated journey of living with chronic diseases, with a goal of helping them self-manage their conditions, while connecting them to their own healthcare team.
About Welldoc
About Astellas
Astellas Pharma Inc., based in Tokyo, Japan, is a company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products. For more information, please visit our website at www.astellas.com/en
Empowering diabetes patients worldwide to improve self-management
Welldoc’s award-winning, digital health product BlueStar, is backed by seven FDA 510 (k) clearance approvals and brings the latest in technology  advancements, including Continuous Glucose Monitoring (CGM), to help people with diabetes gain control of their health.
Top Clinical App for Diabetes MedTech Breakthrough Awards
2017
Best Established App
Digital Diabetes Congress
2019
Best Personal Health App  MedTech Breakthrough Awards
2019
“Astellas is a critical partner as Welldoc looks to broaden our platform into other therapeutic areas as well as expand into other global markets.”
-Kevin McRaith, President & CEO, Welldoc, Inc.
Learn More
Learn More
TYPE OF ORGANIZATION
Employer
Employer
Health System
Health System
Health Plan
Health Plan
Media
Media
COMPANY EMAIL
LAST NAME
FIRST NAME
Stay Up-to-Date with Welldoc!
Astellas and Welldoc Enter into Strategic Alliance for Digital Therapeutics
Welldoc and Astellas are collaborating to develop and commercialize digital health solutions globally for multiple therapeutic areas, including in Japan for diabetes patients.
PR & Communications
443-692-3107
About Welldoc
Media Contact
Welldoc® is a leading digital health company revolutionizing chronic disease management to help transform lives. BlueStar® helps guide individuals through the complicated journey of living with chronic diseases, with a goal of helping them self-manage their conditions, while connecting them to their own healthcare team.
marketing@welldoc.com
About Astellas
Astellas Pharma Inc., based in Tokyo, Japan, is a company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products. For more information, please visit our website at www.astellas.com/en
Empowering diabetes patients worldwide to improve self-management
Welldoc’s award-winning, digital health product BlueStar, is backed by seven FDA 510 (k) clearance approvals and brings the latest in technology  advancements, including Continuous Glucose Monitoring (CGM), to help people with diabetes gain control of their health.
Best Personal Health App  MedTech Breakthrough Awards
2019
Best Established App  
Digital Diabetes Congress
2019
Top Clinical App for Diabetes  MedTech Breakthrough Awards
2017
“Astellas is a critical partner as Welldoc looks to broaden our platform into other therapeutic areas as well as expand into other global markets.”
-Kevin McRaith, President & CEO, Welldoc, Inc.
Welldoc and Astellas are collaborating to develop and commercialize digital health solutions globally for multiple therapeutic areas, including in Japan for diabetes patients.
Learn More
Learn More
TYPE OF ORGANIZATION
Employer
Employer
Health System
Health System
Health Plan
Health Plan
Media
Media
COMPANY EMAIL
FIRST NAME
LAST NAME
Stay Up-to-Date with Welldoc!
Astellas and Welldoc Enter into Strategic Alliance for Digital Therapeutics
443-692-3107
marketing@welldoc.com
PR & Communications
About Welldoc
Media Contact
Welldoc® is a leading digital health company revolutionizing chronic disease management to help transform lives. BlueStar helps guide individuals through the complicated journey of living with chronic diseases, with a goal of helping them self-manage their conditions, while connecting them to their own healthcare team.
About Astellas
Astellas Pharma Inc., based in Tokyo, Japan, is a company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products. For more information, please visit our website at www.astellas.com/en
Top Clinical App for Diabetes  MedTech Breakthrough Awards
2017
Best Established App
Digital Diabetes Congress
2019
Best Personal Health App  MedTech Breakthrough Awards
2019
Empowering diabetes patients worldwide to improve self-management
Welldoc’s award-winning, digital health product BlueStar, is backed by seven FDA 510 (k) clearance approvals and brings the latest in technology  advancements, including Continuous Glucose Monitoring (CGM), to help people with diabetes gain control of their health.
“Astellas is a critical partner as Welldoc looks to broaden our platform into other therapeutic areas as well as expand into other global markets.”
-Kevin McRaith, President & CEO, Welldoc, Inc.
TYPE OF ORGANIZATION
Employer
Employer
Health System
Health System
Health Plan
Health Plan
Media
Media
Learn More
Learn More
COMPANY EMAIL
LAST NAME
FIRST NAME
Stay Up-to-Date with Welldoc!
Welldoc and Astellas are collaborating to develop and commercialize digital health solutions globally for multiple therapeutic areas, including in Japan for diabetes patients.
Astellas and Welldoc Enter into Strategic Alliance for Digital Therapeutics
marketing@welldoc.com
443-692-3107
PR & Communications
Media Contact
About Welldoc
Welldoc® is a leading digital health company revolutionizing chronic disease management to help transform lives. BlueStar® helps guide individuals through the complicated journey of living with chronic diseases, with a goal of helping them self-manage their conditions, while connecting them to their own healthcare team.
Astellas Pharma Inc., based in Tokyo, Japan, is a company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products. For more information, please visit our website at www.astellas.com/en
About Astellas
Empowering diabetes patients worldwide to improve self-management
Welldoc’s award-winning, digital health product BlueStar, is backed by seven FDA 510 (k) clearance approvals and brings the latest in technology  advancements, including Continuous Glucose Monitoring (CGM), to help people with diabetes gain control of their health.
Best Personal Health App  MedTech Breakthrough Awards
2019
Best Established App  
Digital Diabetes Congress
2019
Top Clinical App for Diabetes  MedTech Breakthrough Awards
2017
“Astellas is a critical partner as Welldoc looks to broaden our platform into other therapeutic areas as well as expand into other global markets.”
Welldoc and Astellas are collaborating to develop and commercialize digital health solutions globally for multiple therapeutic areas, including in Japan for diabetes patients.
Learn More
Learn More
TYPE OF ORGANIZATION
Employer
Employer
Health System
Health System
Health Plan
Health Plan
Media
Media
COMPANY EMAIL
LAST NAME
FIRST NAME
Stay Up-to-Date with Welldoc!
Astellas and Welldoc Enter into Strategic Alliance for Digital Therapeutics